Clinical trial
Alzheimer's Disease: Therapeutic Potential of Estrogen
NCT00066157 · University of Wisconsin, Madison, Other · Completed
Key facts
| NCT number | NCT00066157 |
|---|---|
| Title | Alzheimer's Disease: Therapeutic Potential of Estrogen |
| Official title | Alzheimer's Disease: Therapeutic Potential of Estrogen |
| Lead sponsor | University of Wisconsin, Madison, Other |
| Collaborators | National Institute on Aging (NIA) NIH |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Alzheimer Disease |
| Intervention type | Drug |
| Interventions | Transdermal estradiol, Medroxyprogesterone, Placebo Patch, Placebo |
| Enrollment | 42 |
| Start date | Sep 1, 2001 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Aug 5, 2003 |
| Last update posted | Aug 23, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: